Zhejiang Orient Gene Biotech Co., Ltd (SHSE: 688298)
Health Care · Biotechnology · CN
CN¥19.50
+0.67% today · -23.6% 1Y
Zhejiang Orient Gene Biotech Co., Ltd (SHSE: 688298) operates in the Biotechnology industry within the Health Care sector. The company is valued at $557.20M and employs 2,068 people.
Over the last twelve months the share price has lost 23.6%, trading between 17.03 and 28.99.
Tweenvest scores Zhejiang Orient Gene Biotech Co., Ltd across four factors: quality 58/100, value 76/100, growth 0/100. Its strongest factor is value.
688298 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $557.20M
- Revenue (TTM)
- $148.46M
- P/E
- —
- EPS
- -3.31
- Dividend yield
- —
- Beta (5Y)
- 0.82
- 52-week high
- CN¥28.99
- 52-week low
- CN¥17.03
- Avg volume (3M)
- —
- Shares outstanding
- 191.40M
- Employees
- 2,068
- Next earnings
- —
About Zhejiang Orient Gene Biotech Co., Ltd
Zhejiang Orient Gene Biotech Co., Ltd researches and develops, produces, and sells in vitro diagnostic products worldwide. Its products include POCT instant diagnostic reagents, used for detection of infectious diseases, drugs of abuse, fertility, tumor marker, and cardiac marker detection. The company offers its products for various categories, including COVID-19 diagnosis solutions; immunological diagnosis; quantum-beads flowcytometry; instrument; dry biochemical strips; raw materials; FISH probes; animal health; biochemistry; molecular diagnosis; and quantum-beads multiplex. Zhejiang Orient Gene Biotech Co., Ltd was founded in 2005 and is based in Huzhou, China.
- ISIN
- CNE100003RM8
- Founded
- 2005
- Listed since
- Feb 5, 2020
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Guangdong Hybribio Biotech Co.,Ltd.SZSE: 300639 | $575.67M | CN¥6.14 | -2.07% |
| Pharmicell Co., Ltd.KOSE: A005690 | $573.98M | ₩12,860.00 | +3.71% |
| Shanghai Serum Bio-Technology Co., Ltd.SHSE: 688163 | $563.39M | CN¥34.87 | -12.83% |
| Shanghai MicuRx Pharmaceutical Co., Ltd.SHSE: 688373 | $561.38M | CN¥5.73 | -0.87% |
| DBV Technologies S.A.ENXTPA: DBV | $555.98M | €1.68 | -11.87% |
| Jacobio Pharmaceuticals Group Co., Ltd.SEHK: 1167 | $555.24M | HK$5.57 | -7.40% |
| Jiangsu Sihuan Bioengineering Co., LtdSZSE: 000518 | $553.35M | CN¥3.60 | +0.28% |
| Thalys Medical Technology Group CorporationSHSE: 603716 | $545.42M | CN¥16.47 | -0.90% |
Figures last refreshed Oct 11, 2026.